Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvorexant for Bipolar Depression with Insomnia
NCT03764683Phase 4Withdrawn
- Sponsor
- Massachusetts General Hospital
- Start
- Feb 2019
- Primary completion
- Jan 2021
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of suvorexant in bipolar disorder (BD), Insomnia, sponsored by Massachusetts General Hospital. Planned start Feb 2019; status: withdrawn.
02
Drugs
suvorexant
03
Conditions
bipolar disorder (BD)Insomnia
Beyond the preview
Go deeper on NCT03764683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03764683.